Nature Communications (Apr 2024)

CD8+ T-cell responses towards conserved influenza B virus epitopes across anatomical sites and age

  • Tejas Menon,
  • Patricia T. Illing,
  • Priyanka Chaurasia,
  • Hayley A. McQuilten,
  • Chloe Shepherd,
  • Louise C. Rowntree,
  • Jan Petersen,
  • Dene R. Littler,
  • Grace Khuu,
  • Ziyi Huang,
  • Lilith F. Allen,
  • Steve Rockman,
  • Jane Crowe,
  • Katie L. Flanagan,
  • Linda M. Wakim,
  • Thi H. O. Nguyen,
  • Nicole A. Mifsud,
  • Jamie Rossjohn,
  • Anthony W. Purcell,
  • Carolien E. van de Sandt,
  • Katherine Kedzierska

DOI
https://doi.org/10.1038/s41467-024-47576-y
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 21

Abstract

Read online

Abstract Influenza B viruses (IBVs) cause substantive morbidity and mortality, and yet immunity towards IBVs remains understudied. CD8+ T-cells provide broadly cross-reactive immunity and alleviate disease severity by recognizing conserved epitopes. Despite the IBV burden, only 18 IBV-specific T-cell epitopes restricted by 5 HLAs have been identified currently. A broader array of conserved IBV T-cell epitopes is needed to develop effective cross-reactive T-cell based IBV vaccines. Here we identify 9 highly conserved IBV CD8+ T-cell epitopes restricted to HLA-B*07:02, HLA-B*08:01 and HLA-B*35:01. Memory IBV-specific tetramer+CD8+ T-cells are present within blood and tissues. Frequencies of IBV-specific CD8+ T-cells decline with age, but maintain a central memory phenotype. HLA-B*07:02 and HLA-B*08:01-restricted NP30-38 epitope-specific T-cells have distinct T-cell receptor repertoires. We provide structural basis for the IBV HLA-B*07:02-restricted NS1196-206 (11-mer) and HLA-B*07:02-restricted NP30-38 epitope presentation. Our study increases the number of IBV CD8+ T-cell epitopes, and defines IBV-specific CD8+ T-cells at cellular and molecular levels, across tissues and age.